Elizabeth Hoban1, Lisa Gold1, Freya J I Fowkes2,3,4. 1. School of Health and Social Development, Faculty of Health, Deakin University, VIC, Australia. 2. Disease Elimination Program, Burnet Institute, VIC, Australia. 3. Melbourne School of Population and Global Health, University of Melbourne, VIC, Australia. 4. Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia.
Abstract
BACKGROUND: In parallel with the change of malaria policy from control to elimination and declines in the malaria burden in Greater Mekong Sub-region, the motivation and social role of malaria volunteers has declined. To address this public health problem, in Myanmar, the role and responsibilities of malaria volunteers have been transformed into integrated community malaria volunteers (ICMV), that includes the integration of activities for five additional diseases (dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and leprosy) into their current activities. However, this transformation was not evidence-based and did not consider inputs of different stakeholders. Therefore, qualitative stakeholder consultations were performed to optimize future malaria volunteer models in Myanmar. METHODS: Semi-structured interviews were conducted with key health stakeholders from the Myanmar Ministry of Health and Sports (MoHS) and malaria implementing partners to obtain their perspectives on community-delivered malaria models. A qualitative descriptive approach was used to explore the experiences of the stakeholders in policymaking and programme implementation. Interview topic guides were used during the interviews and inductive thematic data analysis was performed. RESULTS: While ICMVs successfully provided malaria services in the community, the stakeholders considered the ICMV model as not optimal and suggested that many aspects needed to be improved including better training, supervision, support, and basic health staff's recognition for ICMVs. Stakeholders believe that the upgraded ICMV model could contribute significantly to achieving malaria elimination and universal health care in Myanmar. DISCUSSION AND CONCLUSION: In the context of high community demand for non-malaria treatment services from volunteers, the integrated volunteer service package must be developed carefully in order to make it effective in malaria elimination programme and to contribute in Myanmar's pathway to universal health coverage (UHC), but without harming the community. An evidenced-based, community-delivered and preferred model, that is also accepted by the MoHS, is yet to be developed to effectively contribute to achieving malaria elimination and UHC goals in Myanmar by 2030.
BACKGROUND: In parallel with the change of malaria policy from control to elimination and declines in the malaria burden in Greater Mekong Sub-region, the motivation and social role of malaria volunteers has declined. To address this public health problem, in Myanmar, the role and responsibilities of malaria volunteers have been transformed into integrated community malaria volunteers (ICMV), that includes the integration of activities for five additional diseases (dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and leprosy) into their current activities. However, this transformation was not evidence-based and did not consider inputs of different stakeholders. Therefore, qualitative stakeholder consultations were performed to optimize future malaria volunteer models in Myanmar. METHODS: Semi-structured interviews were conducted with key health stakeholders from the Myanmar Ministry of Health and Sports (MoHS) and malaria implementing partners to obtain their perspectives on community-delivered malaria models. A qualitative descriptive approach was used to explore the experiences of the stakeholders in policymaking and programme implementation. Interview topic guides were used during the interviews and inductive thematic data analysis was performed. RESULTS: While ICMVs successfully provided malaria services in the community, the stakeholders considered the ICMV model as not optimal and suggested that many aspects needed to be improved including better training, supervision, support, and basic health staff's recognition for ICMVs. Stakeholders believe that the upgraded ICMV model could contribute significantly to achieving malaria elimination and universal health care in Myanmar. DISCUSSION AND CONCLUSION: In the context of high community demand for non-malaria treatment services from volunteers, the integrated volunteer service package must be developed carefully in order to make it effective in malaria elimination programme and to contribute in Myanmar's pathway to universal health coverage (UHC), but without harming the community. An evidenced-based, community-delivered and preferred model, that is also accepted by the MoHS, is yet to be developed to effectively contribute to achieving malaria elimination and UHC goals in Myanmar by 2030.
Entities:
Keywords:
Community-delivered model; Malaria elimination; Myanmar; Primary health care; Volunteer
Authors: Agbessi Amouzou; Elizabeth Hazel; Bryan Shaw; Nathan P Miller; Mengistu Tafesse; Yared Mekonnen; Lawrence H Moulton; Jennifer Bryce; Robert E Black Journal: Am J Trop Med Hyg Date: 2016-01-19 Impact factor: 2.345
Authors: Alistair R D McLean; Hla Phyo Wai; Aung Myat Thu; Zay Soe Khant; Chanida Indrasuta; Elizabeth A Ashley; Thar Tun Kyaw; Nicholas P J Day; Arjen Dondorp; Nicholas J White; Frank M Smithuis Journal: BMC Med Date: 2018-10-22 Impact factor: 8.775
Authors: Kheng Chheng; Michael J Carter; Kate Emary; Ngoun Chanpheaktra; Catrin E Moore; Nicole Stoesser; Hor Putchhat; Soeng Sona; Sin Reaksmey; Paul Kitsutani; Borann Sar; H Rogier van Doorn; Nguyen Hanh Uyen; Le Van Tan; Daniel H Paris; Daniel Paris; Stuart D Blacksell; Premjit Amornchai; Vanaporn Wuthiekanun; Christopher M Parry; Nicholas P J Day; Varun Kumar Journal: PLoS One Date: 2013-04-09 Impact factor: 3.240
Authors: Mayfong Mayxay; Josée Castonguay-Vanier; Vilada Chansamouth; Audrey Dubot-Pérès; Daniel H Paris; Rattanaphone Phetsouvanh; Jarasporn Tangkhabuanbutra; Phouvieng Douangdala; Saythong Inthalath; Phoutthalavanh Souvannasing; Günther Slesak; Narongchai Tongyoo; Anisone Chanthongthip; Phonepasith Panyanouvong; Bountoy Sibounheuang; Koukeo Phommasone; Michael Dohnt; Darouny Phonekeo; Bouasy Hongvanthong; Sinakhone Xayadeth; Pakapak Ketmayoon; Stuart D Blacksell; Catrin E Moore; Scott B Craig; Mary-Anne Burns; Frank von Sonnenburg; Andrew Corwin; Xavier de Lamballerie; Iveth J González; Eva Maria Christophel; Amy Cawthorne; David Bell; Paul N Newton Journal: Lancet Glob Health Date: 2013-07 Impact factor: 26.763